Advanced search
Start date
Betweenand


Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia

Full text
Author(s):
Cassoli, Juliana S. ; Guest, Paul C. ; Santana, Aline G. ; Martins-de-Souza, Daniel
Total Authors: 4
Document type: Journal article
Source: PROTEOMICS CLINICAL APPLICATIONS; v. 10, n. 4, p. 14-pg., 2016-04-01.
Abstract

Schizophrenia is an incurable neuropsychiatric disorder managed mostly by treatment of the patients with antipsychotics. However, the efficacy of these drugs has remained only low to moderate despite intensive research efforts since the early 1950s when chlorpromazine, the first antipsychotic, was synthesized. In addition, antipsychotic treatment can produce often undesired severe side effects in the patients and addressing these remains a large unmet clinical need. One of the reasons for the low effectiveness of these drugs is the limited knowledge about the molecular mechanisms of schizophrenia, which impairs the development of new and more effective treatments. Recently, proteomic studies of clinical and preclinical samples have identified changes in the levels of specific proteins in response to antipsychotic treatment, which have converged on molecular pathways such as cell communication and signaling, inflammation and cellular growth, and maintenance. The findings of these studies are summarized and discussed in this review and we suggest that this provides validation of proteomics as a useful tool for mining drug mechanisms of action and potentially for pinpointing novel molecular targets that may enable development of more effective medications. (AU)

FAPESP's process: 13/08711-3 - Developing a predictive test for a successful medication response and understanding the molecular bases of schizophrenia through proteomics
Grantee:Daniel Martins-de-Souza
Support Opportunities: Research Grants - Young Investigators Grants
FAPESP's process: 14/14881-1 - Understanding the influence of glycolysis components in the function of oligodendrocytes: linking with findings in schizophrenia
Grantee:Juliana Silva Cassoli
Support Opportunities: Scholarships in Brazil - Post-Doctoral